Asia-Pacific (APAC) Injectable Drug Delivery Market is Poised to Grow at 12.4% To 2024

According to Data Bridge Market Research new Market report “Asia-Pacific APAC Injectable Drug Delivery Market By Type (Devices (Conventional Injection Devices, Self Injection Devices),  Formulations (Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations), By Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology, Others), By Usage Pattern (Curative Care, Immunizations, Other Usage Patterns), By Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), By End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), By Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Phillipines, and Rest of APAC) – Industry Trends and Forecast to 2024”, is estimated at USD 154.0 billion in 2016 and is projected to reach USD 143.1 billion by 2024, at a CAGR of 12.4% during the forecast period from 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Asia-Pacific (APAC) Injectable Drug Delivery Market

Access Report: http://databridgemarketresearch.com/reports/asia-pacific-injectable-drug-delivery-market/

Market Segmentation: Asia-Pacific (APAC) Injectable Drug Delivery Market

  • The APAC Injectable Drug Delivery Market is segmented based on type, applications, usage pattern, mode of administration, end-user and country.
  • Based on type, the apac injectable drug delivery market is segmented into devices and formulations.
  • By product, the needle free ijectors are further segmented into fillable needle-free injectors and prefilled needle-free injectors.
  • By usability the needle free injector is segmented into disposable and reusable injectors.
  • By design, the autoinjectors is segmented into standardized and customizable autoinjectors.
  • On the basis of applications, the apac injectable drug delivery market is segmented into hormonal disorders, oncology, autoimmune diseases, orphan diseases, and others.
  • Based on indications the market is segmented into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.
  • Based on mode of administration the asia-pacific (apac) injectable drug delivery market is segmented into skin, circulatory, organs and central nervous system.
  • On the basis of end user the asia-pacific (apac) injectable drug delivery market is segmented into hospitals, clinics, home care settings, research laboratories and, pharma & biotech companies.
  • On the basis of usage pattern the asia-pacific (apac) injectable drug delivery market is segmented into curative care, immunization, and others.

Geographical Segmentation: Asia-Pacific (APAC) Injectable Drug Delivery Market

Based on geography the asia-pacific (apac) injectable drug delivery market is segmented into 11 major countries such as Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Phillipines, and Rest of APAC.

Competitive Landscape: Asia-Pacific (APAC) Injectable Drug Delivery Market

The market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Some of the major players operating in this market are Baxter International, Inc., Becton, Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, and Teva Pharmaceuticals Industries Ltd.

Browse Related Reports: 

Global Injectable Drug Delivery Market, By Type (Devices (Conventional Injection Devices, Self Injection Devices),  Formulations (Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations), By Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology, Others), By Usage Pattern (Curative Care, Immunizations, Other Usage Patterns), By Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), By End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Industry Trends and Forecast to 2024

http://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/

North America Injectable Drug Delivery Market By Type (Devices (Conventional Injection Devices, Self Injection Devices),Formulations (Conventional Drug Delivery, Noble Drug Delivery, Long Acting Injection Formulations), By Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology, Others), By Usage Pattern (Curative Care, Immunizations, Other Usage Patterns), By Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), By End User (Hospitals, Clinics, Home Care Settings, Research Laboratories, Pharma & Biotech Companies), By Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2024

http://databridgemarketresearch.com/reports/north-america-injectable-drug-delivery-market/